Literature DB >> 20454818

Paraneoplastic pandysautonomia as a manifestation of non-small cell lung cancer.

Kayihan Uluc1, Muge Kocak, Pinar Kahraman Koytak, Deniz Borucu, Baris Isak, Sevinc Aktan, Onder Us.   

Abstract

Pandysautonomia is a severe and rare clinical condition characterized by widespread sympathetic and parasympathetic dysfunction. Consideration of whether symptoms and presentation are acute, subacute, or chronic is often helpful in establishing a differential diagnosis. The underlying mechanisms leading to pure pandysautonomia are unclear; however, there is some evidence suggestive of an immune-mediated pathogenesis. Herein, we report a case with pandysautonomia as a paraneoplastic manifestation of non-small cell lung cancer that had an excellent response to symptomatic and supportive treatments, as well as IVIG therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454818     DOI: 10.1007/s10072-010-0288-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

Review 1.  Paraneoplastic syndromes of the peripheral nerves.

Authors:  Stacy A Rudnicki; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2005-10       Impact factor: 5.710

2.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.

Authors:  S Vernino; P A Low; R D Fealey; J D Stewart; G Farrugia; V A Lennon
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

3.  Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.

Authors:  C A Vedeler; J C Antoine; B Giometto; F Graus; W Grisold; I K Hart; J Honnorat; P A E Sillevis Smitt; J J G M Verschuuren; R Voltz
Journal:  Eur J Neurol       Date:  2006-07       Impact factor: 6.089

4.  Treatment of acute pandysautonomia with intravenous immunoglobulin.

Authors:  R A Mericle; W J Triggs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

Review 5.  Autonomic neuropathies.

Authors:  P A Low
Journal:  Curr Opin Neurol       Date:  1994-10       Impact factor: 5.710

Review 6.  Autonomic paraneoplastic neurological syndromes.

Authors:  Lorenzo Lorusso; Ian K Hart; Daniela Ferrari; Gaelle K Ngonga; Chiara Gasparetto; Giovanni Ricevuti
Journal:  Autoimmun Rev       Date:  2006-11-17       Impact factor: 9.754

7.  Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.

Authors:  Sean J Pittock; Thomas J Kryzer; Vanda A Lennon
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

Review 8.  Autonomic dysfunction in peripheral nerve disease.

Authors:  Phillip A Low; Steven Vernino; Guillermo Suarez
Journal:  Muscle Nerve       Date:  2003-06       Impact factor: 3.217

9.  Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments.

Authors:  Andrew McKeon; Vanda A Lennon; Daniel H Lachance; Robert D Fealey; Sean J Pittock
Journal:  Arch Neurol       Date:  2009-06

10.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.

Authors:  S Younes-Mhenni; M F Janier; L Cinotti; J C Antoine; F Tronc; V Cottin; P J Ternamian; P Trouillas; J Honnorat
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.